Ordinary Rebalance | Solactive Global Healthcare Exposure Index | Effective Date 2nd November 2023
In the ordinary rebalance, the following composition will be implemented effective open 02.11.2023:
| ABBVIE INC |
| AGC INC |
| ALFRESA HOLDINGS CORP ORD |
| AMGEN INC |
| ASAHI KASEI CORP |
| BRISTOL-MYERS SQUIBB CO |
| CANON INC |
| ESSITY AB CLASS B |
| GILEAD SCIENCES INC |
| GSK PLC |
| JOHNSON & JOHNSON |
| MEDTRONIC PLC |
| MERCK & CO. INC. |
| MITSUBISHI CHEMICAL GROUP |
| NISSAN CHEMICAL CORP |
| NITTO DENKO CORP |
| NOVARTIS AG |
| ONO PHARMACEUTICAL CO LTD ORD |
| PFIZER INC |
| PROCTER & GAMBLE CO |
| RECKITT BENCKISER GROUP PLC |
| ROCHE HOLDING AG |
| ROYALTY PHARMA PLC- CL A |
| SANOFI SA |
| SBI HOLDINGS INC ORD |
| SEKISUI CHEMICAL CO LTD ORD |
| SUMITOMO CHEMICAL CO LTD |
| TAKEDA PHARMACEUTICAL |
| TORAY INDUSTRIES INC ORD |
| TOSOH CORP |